Future Financial Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Future Financial Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,000	Closed	-$20.2K	–	405
2025 Q3	$20.2K	Hold	1,000	–	–	0.01%	335
2025 Q2	$16.8K	Hold	1,000	–	–	0.01%	337
2025 Q1	$15.4K	Hold	1,000	–	–	0.01%	341
2024 Q4	$22K	Hold	1,000	–	–	0.02%	313
2024 Q3	$18K	Buy	+1,000	New	+$17.5K	0.01%	343
2024 Q2	–	Sell	-1,000	Closed	-$14.1K	–	432
2024 Q1	$14.1K	Buy	+1,000	New	+$12.6K	0.01%	378
2022 Q2	–	Sell	-5,900	Closed	-$55K	–	441
2022 Q1	$55K	Hold	5,900	–	–	0.05%	254
2021 Q4	$49K	Buy	+5,900	New	+$53.3K	0.04%	279

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Future Financial Wealth Management's TEVA Position: Q4 2025 in Review

Future Financial Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2025, closing a stake of 1,000 shares — an estimated $20.2K sold.

Future Financial Wealth Management first reported a position in TEVA in Q4 2021 and held it in 8 quarters. The position peaked at $55K in Q1 2022. 631 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

Future Financial Wealth Management reported no remaining Teva Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Future Financial Wealth Management sold 1,000 Teva Pharmaceuticals shares in Q4 2025, an estimated $20.2K.
Future Financial Wealth Management first reported a position in Teva Pharmaceuticals in Q4 2021 and held it in 8 quarters.
Future Financial Wealth Management's Teva Pharmaceuticals position peaked at $55K in Q1 2022.
631 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2025.

Based on Future Financial Wealth Management's 13F filing for Q4 2025, filed 21 Jan 2026.